Fast and Accurate Antibody Sequence Design via Structure Retrieval
Xingyi Zhang, Kun Xie, Ningqiao Huang, Wei Liu, Peilin Zhao, Sibo Wang, Kangfei Zhao, Biaobin Jiang
TL;DR
Antibody design often suffers from hallucinations when inferring CDR sequences from backbone structures via inverse folding. IgSeek addresses this by retrieving structurally similar CDR templates from a natural antibody database using a MEGNN-encoded vector space to guide sequence design, followed by ensemble-based sequence prediction from the retrieved templates. The approach yields faster structure retrieval than state-of-the-art methods and higher sequence-recovery accuracy across CDR types, with strong generalization to T-cell receptors and substantial efficiency gains (about $20$-fold faster inference on OAS-H3). This retrieval-augmented framework offers a scalable, practical pathway for rapid and accurate therapeutic protein design, including antibodies and receptors.
Abstract
Recent advancements in protein design have leveraged diffusion models to generate structural scaffolds, followed by a process known as protein inverse folding, which involves sequence inference on these scaffolds. However, these methodologies face significant challenges when applied to hyper-variable structures such as antibody Complementarity-Determining Regions (CDRs), where sequence inference frequently results in non-functional sequences due to hallucinations. Distinguished from prevailing protein inverse folding approaches, this paper introduces Igseek, a novel structure-retrieval framework that infers CDR sequences by retrieving similar structures from a natural antibody database. Specifically, Igseek employs a simple yet effective multi-channel equivariant graph neural network to generate high-quality geometric representations of CDR backbone structures. Subsequently, it aligns sequences of structurally similar CDRs and utilizes structurally conserved sequence motifs to enhance inference accuracy. Our experiments demonstrate that Igseek not only proves to be highly efficient in structural retrieval but also outperforms state-of-the-art approaches in sequence recovery for both antibodies and T-Cell Receptors, offering a new retrieval-based perspective for therapeutic protein design.
